A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas - PubMed

A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas - PubMed

A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas

Nayuta Higa 1, Toshiaki Akahane 2 3, Seiya Yokoyama 2, Hajime Yonezawa 1, Hiroyuki Uchida 1, Tomoko Takajo 1, Mari Kirishima 2, Taiji Hamada 2, Kei Matsuo 2, Shingo Fujio 1, Tomoko Hanada 1, Hiroshi Hosoyama 1, Masanori Yonenaga 1, Akihisa Sakamoto 1, Tsubasa Hiraki 2, Akihide Tanimoto 2 3, Koji Yoshimoto 1

Affiliations 

• PMID: 32748499
 
• DOI: 10.1111/cas.14597

Free article

Abstract

Central nervous system tumors are classified based on an integrated diagnosis combining histology and molecular characteristics, including IDH1/2 and H3-K27M mutations, as well as 1p/19q codeletion. Here, we aimed to develop and assess the feasibility of a glioma-tailored 48-gene next-generation sequencing (NGS) panel for integrated glioma diagnosis. We designed a glioma-tailored 48-gene NGS panel for detecting 1p/19q codeletion and mutations in IDH1/2, TP53, PTEN, PDGFRA, NF1, RB1, CDKN2A/B, CDK4, and the TERT promoter (TERTp). We analyzed 106 glioma patients (grade II: 19 cases, grade Ⅲ: 23 cases, grade Ⅳ: 64 cases) using this system. The 1p/19q codeletion was detected precisely in oligodendroglial tumors using our NGS panel. In a cohort of 64 grade Ⅳ gliomas, we identified 56 IDH-wildtype glioblastomas. Within these IDH-wildtype glioblastomas, 33 samples (58.9%) showed a mutation in TERTp. Notably, PDGFRA mutations and their amplification were more commonly seen in TERTp-wildtype glioblastomas (43%) than in TERTp-mutant glioblastomas (6%) (p = 0.001). Hierarchical molecular classification of IDH-wildtype glioblastomas revealed three distinct groups of IDH-wildtype glioblastomas. One major cluster was characterized by mutations in PDGFRA, amplification of CDK4 and PDGFRA, homozygous deletion of CDKN2A/B, and absence of TERTp mutations. This cluster was significantly associated with older age (p = 0.021), higher Ki-67 score (p = 0.007), poor prognosis (p=0.012), and a periventricular tumor location. We report the development of a glioma-tailored NGS panel for detecting 1p/19q codeletion and driver gene mutations on a single platform. Our panel identified distinct subtypes of IDH- and TERTp-wildtype glioblastomas with frequent PDGFRA alterations.

Keywords: 1p/19q codeletion; PDGFRA alterations; TERT promoter; glioblastoma; next-generation sequencing.

This article is protected by copyright. All rights reserved.

Similar articles

• Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.

  Brito C, Azevedo A, Esteves S, Marques AR, Martins C, Costa I, Mafra M, Bravo Marques JM, Roque L, Pojo M.BMC Cancer. 2019 Oct 17;19(1):968. doi: 10.1186/s12885-019-6177-0.PMID: 31623593 Free PMC article.
• Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.

  Pekmezci M, Rice T, Molinaro AM, Walsh KM, Decker PA, Hansen H, Sicotte H, Kollmeyer TM, McCoy LS, Sarkar G, Perry A, Giannini C, Tihan T, Berger MS, Wiemels JL, Bracci PM, Eckel-Passow JE, Lachance DH, Clarke J, Taylor JW, Luks T, Wiencke JK, Jenkins RB, Wrensch MR.Acta Neuropathol. 2017 Jun;133(6):1001-1016. doi: 10.1007/s00401-017-1690-1. Epub 2017 Mar 2.PMID: 28255664 Free PMC article. Clinical Trial.
• Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel.

  Zacher A, Kaulich K, Stepanow S, Wolter M, Köhrer K, Felsberg J, Malzkorn B, Reifenberger G.Brain Pathol. 2017 Mar;27(2):146-159. doi: 10.1111/bpa.12367. Epub 2016 Apr 19.PMID: 26919320
• Molecular Testing of Brain Tumor.

  Park SH, Won J, Kim SI, Lee Y, Park CK, Kim SK, Choi SH.J Pathol Transl Med. 2017 May;51(3):205-223. doi: 10.4132/jptm.2017.03.08. Epub 2017 May 12.PMID: 28535583 Free PMC article. Review.
• [Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors. German version].

  Malzkorn B, Reifenberger G.Pathologe. 2019 Mar;40(2):131-139. doi: 10.1007/s00292-019-0575-6.PMID: 30790013 Review. German.